Evidence map›Paper›PMID 29031947›Full record

ArticleThe Journal of thoracic and cardiovascular surgery2018

The long-term survival of robotic lobectomy for non-small cell lung cancer: A multi-institutional study.

Robert J Cerfolio, Asem F Ghanim, Mark Dylewski, Giulia Veronesi, Lorenzo Spaggiari, Bernard J Park

Open access · bronzeAbstract readMulticenter StudyVideo-Audio Media
In one paragraph

Article in The Journal of thoracic and cardiovascular surgery, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 71 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
71citing papers in PubMed, 1 pooled it
12.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

71 citing papers in PubMed, 1 synthesis or guideline pooled it, 141 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Observational
  4. Article
  5. Review
  6. Article
  7. Robotic Thoracic Surgery: Current Landscape and Future Directions.Interdisciplinary cardiovascular and thoracic surgery · 2026
    Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Uniportal robotic thoracic surgery - an early Indian experience.Indian journal of thoracic and cardiovascular surgery · 2025
    Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review

11 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 2 countries.

Robert J CerfolioDivision of Thoracic Surgery, University of Alabama - Birmingham, Birmingham, Ala. Electronic address: robert.cerfolio@nyu.org.
Asem F GhanimDivision of Thoracic Surgery, University of Alabama - Birmingham, Birmingham, Ala.
Mark DylewskiDivision of Thoracic Surgery, Baptist Health of South Florida, Miami, Fla.
Giulia VeronesiDivision of Thoracic Surgery, Istituto Clinico Humanitas Cancer Center, Rozzano, Milan, Italy; Istituto Europeo Di Oncologia, Milan, Italy.
Lorenzo SpaggiariIstituto Europeo Di Oncologia, Milan, Italy.
Bernard J ParkThoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY.
University of Alabama at Birmingham · USBaptist Health South Florida · USEuropean Institute of Oncology · ITFondazione Humanitas per la Ricerca · ITMemorial Sloan Kettering Cancer Center · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

objectiveOur objective is to report the world's largest series with the longest follow-up of robotic lobectomy for non-small cell lung cancer (NSCLC).

methodsThis was a multi-institutional retrospective review of a consecutive series of patients from 4 institutions' prospective robotic databases.

resultsThere were 1339 patients (men 55%, median age 68 years). The median operative time was 136 minutes, median number of lymph nodes was 13 (5 N2 stations and 1 N1), median blood loss was 50 cc, and 4 (0.005%) patients received intraoperative transfusions. Conversions occurred in 116 patients (9%) and for bleeding in 24 (2%). Median length of stay was 3 days. Major morbidity occurred in 8%. The 30-day and 90-day operative mortality was 0.2% and 0.5%, respectively. Follow-up was complete in 99% of patients with a median follow-up of 30 months (range 1-154 months). The 5-year stage-specific survival was: 83% for the 672 patients with stage IA NSCLC, 77% for the 281 patients with stage IB, 68% for the 118 patients with stage IIA, 70% for 99 patients with IIB, 62% for 143 patients with stage IIIA (122 had N2 disease, 73%), and 31% for 8 patients with stage IIIB (none had N3 disease). The cumulative incidence of metastatic NSCLC was 15% (128 patients, 95% confidence interval, 13%-18%). The cumulative incidence of local recurrence in the ipsilateral operated chest was 3% only (26 patients, 95% confidence interval, 2%-5%).

conclusionsThe oncologic results of robotic lobectomy for NSCLC are promising, especially for patients with pathologic N2 disease. However, further follow-up and studies are needed.

Indexed as

AdultAgedAged, 80 and overBlood Loss, SurgicalBlood TransfusionCarcinoma, Non-Small-Cell LungDatabases, FactualFemaleHumansItalyLength of StayLung NeoplasmsMaleMiddle AgedNeoplasm Recurrence, LocalNeoplasm Staginglung cancerquality outcomesrobotic surgerysurvival

Identifiers

PMID29031947
PMCPMC5896345
OpenAlexW3199362594

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.